s6y
Company name or ticker
Search
Helus Pharma Inc.
6-K
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Filed
Friday, November 13, 2026
Period
Nov 13, 2026
Accession number
0001833141-26-000100
Documents
6-K
6-K
EX-99.1
EX-99.1
EX-99.2
EX-99.2
EX-99.3
EX-99.3
EX-99.4
EX-99.4
On sec.gov
Filing index
All files
Complete submission text
SGML header